AMERICAN PHARMACISTS ASSOCIATION for AMERICAN PHARMACISTS ASSOCIATION
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
H.R. 3700/ S. 1951 Fair Medicaid Drug Payment Act of 2007 H.R. 3140 Saving Our Community Pharmacies Act of 2007 S. 3101/ H.R. 6331 Medicare Patients and Providers Act of 2008 sections on AMP, Prompt Payment of Part D Claims, DME Competitive Bidding, and Prescription Drug Pricing Updates H.R. 6252/ S. 3144 Medicare DMEPOS Competitive Acquisition Reform Act of 2008 H.R. 5780 Medicare Clinical Practitioner Services Coverage Act of 2008 H.R. 5613 Medicaid Safety Net Act of 2008 H.R. 2408/ S. 2408 Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007 H.R. 971 Community Pharmacy Fairness Act S. 1827 Pharmacist Access and Recognition in Medicare (PhARM) of 2007 S. 1474 Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007 H.R. 3025 Medicare Prescription Drug Savings for Our Seniors Act of 2007 S. 1954 Pharmacy Access Improvement Act (PhAIM) of 2007 (Public Law 110-28 and Public Law 110-90) Medicaid's Tamper-Resistance Prescription Pad Requirement (Public Law 109-171) Deficit Reduction Act of 2005 section on Average Manufacturers Price (AMP) (Docket Number: CMS -4119-F) Medicare Program; Medicare Part D Claims Data (Docket Number: CMS 4131P) Medicare Program; Revisions to the Medicare Advantage and Prescription Drug Benefit Programs; Proposed Rule (Docket Number: CMS-2238-IFC) Medicaid Program; Multiple Source Drug Definition DRAFT and FINAL CMS 2009 Medicare Part D Call Letter (Docket Number: CMS0016F and CMS0018F) Medicare Program; Standards for E-Prescribing Under Medicare Part D and Identification of Backward Compatible Version of Adopted Standard for EPrescribing and the Medicare Prescriptions Drug Program (Version 8.1); Final Rule (Docket Numeber: CMS-2008-0009-0002)Medicare Program; Option for Prescription Drug Plans to Lower their Premiums for Low-Income Subsidy Beneficiaries
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARCIE BOUGH | Former Legislative Assistant in Senate |
| HARRY HAGEL New | — |
| HRANT JAMGOCHIAN | — |
| KRISTINA E LUNNER | — |
Health Issues HCR
H.R. 1343 Health Centers Renewal Act of 2008 H.R. 2994 National Pain Care Policy Act of 2007 H.R. 1108/ S. 265 Family Smoking Prevention and Tobacco Control Act Under Line 17: We would like to include HHS - Office of Inspector General (OIG) (Docket Number: HRSA-RIN-0906-AA44) Resignation of Medically Underserved Populations and Health Professional Shortage Areas (Docket Number: OIG-126-PN) Proposed notice; Department of Health and Human Services Office of Inspector General (OIG); Draft OIG Supplemental Compliance Program Guidance for Nursing Facilities sections on pharmacies and pharmacists
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARCIE BOUGH | Legislative Assistant in Senate |
| HARRY HAGEL New | — |
| HRANT JAMGOCHIAN | — |
| KRISTINA E LUNNER | — |
Veterans VET
H.R. 4053 Veterans Mental Health and Other Care Improvements Act of 2008 section on Pain Care Act H.R. 6122 Veterans Pain Care Act of 2008 S. 2669 Veterans Medical Personnel Recruitment and Retention Act of 2008 section on Incentive Pay
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARCIE BOUGH | Former Legislative Assistant in Senate |
| HARRY HAGEL New | — |
| HRANT JAMGOCHIAN | — |
| KRISTINA E LUNNER | — |
Budget/Appropriations BUD
DRAFT Fiscal 2009 Agriculture Appropriations section on FDA Funding
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARCIE BOUGH | Former Legislative Assistant in Senate |
| HARRY HAGEL New | — |
| HRANT JAMGOCHIAN | — |
| KRISTINA E LUNNER | — |
Pharmacy PHA
H. Con. Res. 342 Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest H.R. 6353/ S. 980 Ryan Haight Online Pharmacy Consumer Protection Act of 2008 H.R. 5839 Safeguarding Americas Pharmaceuticals Act of 2008 (Public Law 110-85) Food and Drug Administration Amendment Act of 2007 (FDAAA) sections on Standardization of Prescription Drug Identifiers (Docket Number: FDA-2008-N-0120) and Technology Prescription Drug Identifiers ( Docket Number FDA-2008-N-0120) and Prescription Drug User Fee Act (PDUFA) (Docket Number: FDA-N-0157) FDA Prescription Drug Labeling and Medication Guide (Docket Number DEA218P) Electronic Prescriptions for Controlled Substances (Docket Number: FDA-2008-N-0281-0001) Pilot Program To Evaluate Proposed Name Submissions; Concept Paper; Public Meeting (Docket Number: FDA-2006-N-5015) Content and Format of Labeling for Human Prescription Drug and Biological Products; Requirements for Pregnancy and Lactation Labeling (Docket Number: FDA-2008-N-0257-0001) Prescription Drug User Fee Act (PDUFA) IV Drug Safety Five-Year Plan (Docket Number: FDA-2008-N-0162) Agency Information Collection Activities; Proposed Collection; Comment Request: Prescription Product Labeling: Medication Guide Requirements [related to the Paperwork Reduction Act of 1995] DRAFT Food and Drug Globalization Act of 2008 sections on drug and medical devices
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARCIE BOUGH | Former Legislative Assistant in Senate |
| HARRY HAGEL New | — |
| HRANT JAMGOCHIAN | — |
| KRISTINA E LUNNER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.